Nippon Shinyaku
4516.TSE
30.52 USD
0.45
+1.50%
n
Overview
Last close
30.52 usd
Market cap
2.06B usd
52 week high
38.87 usd
52 week low
20.41 usd
Target price
38.5 usd
Valuation
P/E
10.0799
Forward P/E
12.9199
Price/Sales
1.9403
Price/Book Value
1.1373
Enterprise Value
1.68B usd
EV/Revenue
1.634
EV/EBITDA
5.9063
Key financials
Revenue TTM
1.06B usd
Gross Profit TTM
713.47M usd
EBITDA TTM
273.89M usd
Earnings per Share
3.03 usd
Dividend
0.79 usd
Total assets
2.10B usd
Net debt
-371.78M usd
About
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
- Symbol4516.TSE
- ExchangeTSE
- IsinJP3717600005
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEO
- HeadquarterKyoto
- Web sitehttps://www.nippon-shinyaku.co.jp
